Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.

Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.

There is currently no completely effective therapy available for metastatic pheochromocytomas or paragangliomas. Increasing understanding of the germline and somatic mutations leading to pheochromocytoma and paraganglioma development has revealed crucial insights into the molecular pathology of thes...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Nölting, S, Grossman, AB
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2012

Eitemau Tebyg

Pheochromocytomas and paragangliomas: assessment of malignant potential.
gan: Korevaar, T, et al.
Cyhoeddwyd: (2011)

Pheochromocytomas and paragangliomas: assessment of malignant potential
gan: Korevaar, T, et al.
Cyhoeddwyd: (2011)

Current management of pheochromocytoma/paraganglioma: a guide for the practicing clinician in the era of precision medicine
gan: Nölting, S, et al.
Cyhoeddwyd: (2019)

Pheochromocytomas and secreting paragangliomas
gan: Gimenez-Roqueplo Anne-Paule, et al.
Cyhoeddwyd: (2006-12-01)

Treatment of metastatic pheochromocytoma and paraganglioma with I-131-meta-iodobenzylguanidine (MIBG)
gan: Kaltsas, G, et al.
Cyhoeddwyd: (2003)

CT and MR imaging of unusual locations of extra-adrenal paragangliomas (pheochromocytomas).
gan: Sahdev, A, et al.
Cyhoeddwyd: (2005)

Tumour microenvironment in pheochromocytoma and paraganglioma
gan: Serena Martinelli, et al.
Cyhoeddwyd: (2023-03-01)

Pheochromocytoma/paraganglioma-associated cardiomyopathy
gan: Alicja Szatko, et al.
Cyhoeddwyd: (2023-07-01)

Characteristics of pediatric pheochromocytoma/paraganglioma
gan: Vijaya Sarathi
Cyhoeddwyd: (2017-01-01)

Preoperative Management of Pheochromocytoma and Paraganglioma
gan: Fang Fang, et al.
Cyhoeddwyd: (2020-09-01)

Perioperative management of paragangliomas and pheochromocytomas
gan: Magdalena Fermandois, et al.
Cyhoeddwyd: (2020-03-01)

Immune microenvironment of pheochromocytomas and paragangliomas
gan: ZHOU Yue, TONG Anli
Cyhoeddwyd: (2024-06-01)

Pheochromocytomas and Paragangliomas Diagnosis and Treatment
gan: Jorge Luis Soriano Lorenzo
Cyhoeddwyd: (2021-09-01)

Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force
gan: Eu Jeong Ku, et al.
Cyhoeddwyd: (2021-04-01)

Sex differences in presentation of pheochromocytoma and paraganglioma
gan: Nora Azin Ali, et al.
Cyhoeddwyd: (2025-01-01)

Hereditary and clinical insights into paraganglioma and pheochromocytoma
gan: Caitlin B Mauer Hall, et al.
Cyhoeddwyd: (2024-11-01)

Potential Biomarkers of Metastasizing Paragangliomas and Pheochromocytomas
gan: Anastasiya Snezhkina, et al.
Cyhoeddwyd: (2021-11-01)

Editorial: Predictive tools in pheochromocytoma and paraganglioma
gan: Filippo Ceccato, et al.
Cyhoeddwyd: (2023-06-01)

Cancer Stem Cells in Pheochromocytoma and Paraganglioma
gan: Laura D. Scriba, et al.
Cyhoeddwyd: (2020-02-01)

Update on Modern Management of Pheochromocytoma and Paraganglioma
gan: Jacques W. M. Lenders, et al.
Cyhoeddwyd: (2017-06-01)

Pheochromocytomas and Paragangliomas as Causes of Endocrine Hypertension
gan: Letizia Canu, et al.
Cyhoeddwyd: (2019-06-01)

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
gan: Fishbein, Lauren, et al.
Cyhoeddwyd: (2018)

177Lu-DOTATATE therapy in metastatic/ inoperable pheochromocytoma-paraganglioma
gan: Sanjeet Kumar Jaiswal, et al.
Cyhoeddwyd: (2020-09-01)

SDHB immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: A retrospective and prospective analysis
gan: Tingwei Su, et al.
Cyhoeddwyd: (2023-03-01)

Anti-cancer potential of MAPK pathway inhibition in paragangliomas-effect of different statins on mouse pheochromocytoma cells.
gan: Stephanie M J Fliedner, et al.
Cyhoeddwyd: (2014-01-01)

External beam radiation therapy for advanced/unresectable malignant paraganglioma and pheochromocytoma
gan: William Breen, MD, et al.
Cyhoeddwyd: (2018-01-01)

Paragangliomas/Pheochromocytomas: Clinically Oriented Genetic Testing
gan: Rute Martins, et al.
Cyhoeddwyd: (2014-01-01)

Metyrosine-associated endocrinological changes in pheochromocytoma and paraganglioma
gan: Yuko Matsuo, et al.
Cyhoeddwyd: (2023-10-01)

Clinical presentation of sporadic and hereditary pheochromocytoma/paraganglioma
gan: Sofia Maria Lider Burciulescu, et al.
Cyhoeddwyd: (2023-02-01)

Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma
gan: Bruna Calsina, et al.
Cyhoeddwyd: (2023-02-01)

Whole transcriptome analysis of canine pheochromocytoma and paraganglioma
gan: Marit F. van den Berg, et al.
Cyhoeddwyd: (2023-08-01)

Initial characterization of immune microenvironment in pheochromocytoma and paraganglioma
gan: Bo Jin, et al.
Cyhoeddwyd: (2022-12-01)

Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes
gan: Christie G Turin, et al.
Cyhoeddwyd: (2023-01-01)

Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma
gan: Jiyeon Ahn, et al.
Cyhoeddwyd: (2021-06-01)

Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas.
gan: Kyong Young Kim, et al.
Cyhoeddwyd: (2016-01-01)

DNA methylation analysis in malignant pheochromocytoma and paraganglioma
gan: Toshihiro Oishi, et al.
Cyhoeddwyd: (2017-03-01)

Research in Robot-assisted Surgery for Pheochromocytoma and Paraganglioma
gan: OU Minjie, et al.
Cyhoeddwyd: (2024-07-01)

Metastatic paraganglioma of the spine associated with autosomal dominant hereditary paraganglioma-pheochromocytoma syndrome
gan: Luis A. Castillejo-Adalid, et al.
Cyhoeddwyd: (2022-09-01)

Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas.
gan: Yao, L, et al.
Cyhoeddwyd: (2010)

Circulating GLP-1 Levels in Patients with Pheochromocytoma/Paraganglioma
gan: Nan Chen, et al.
Cyhoeddwyd: (2022-01-01)